UBC Hospital is a health care facility located on the University Endowment Lands in Vancouver, British Columbia, Canada. It opened in 1968, and is now operated by Vancouver Coastal Health.

There are 332 beds in UBC Hospital.

During the past decade, UBC Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UBC Hospital" #1 sponsor was "University of British Columbia" with 7 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Washington University School of Medicine" with 4 trials sponsored, "Biogen" with 2 trials sponsored and "Genzyme, a Sanofi Company" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UBC Hospital" #1 collaborator was "Alzheimer's Association" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Accelerating Medicines Partnership (AMP)" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Avid Radiopharmaceuticals" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "UBC Hospital" are "Alzheimer's Disease" (5 trials), "Alzheimers Disease" (4 trials), "Alzheimers Disease, Familial" (4 trials), "Dementia" (4 trials) and "Multiple Sclerosis, Relapsing-Remitting" (2 trials). Many other conditions were trialed in "UBC Hospital" in a lesser frequency.

Most popular intervention types in "UBC Hospital" are "Drug" (15 trials), "Biological" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Gantenerumab" (4 trials), "Interferon beta-1a" (3 trials), "Matching Placebo (Gantenerumab)" (3 trials) and "E2814" (2 trials). Other intervention names were less common.

The vast majority of trials in "UBC Hospital" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UBC Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in UBC Hospital, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in UBC Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".